By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Stemtech Corporation

Stemtech Corporation (STEK)

OTC Currency in USD
$0.01
$0.00
-3.33%
Last Update: 3 Sept 2025, 17:06
$2.12M
Market Cap
-0.55
P/E Ratio (TTM)
Forward Dividend Yield
$0.01 - $0.07
52 Week Range

STEK Stock Price Chart

Explore Stemtech Corporation interactive price chart. Choose custom timeframes to analyze STEK price movements and trends.

STEK Company Profile

Discover essential business fundamentals and corporate details for Stemtech Corporation (STEK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

26 Nov 2021

Employees

1.00

CEO

Charles S. Arnold

Description

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands. The company is based in Miramar, Florida.

STEK Financial Timeline

Browse a chronological timeline of Stemtech Corporation corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 30 Sept 2023

EPS came in at -$0.01 , while revenue for the quarter reached $1.30M .

Earnings released on 30 Jun 2023

EPS came in at -$0.00 , while revenue for the quarter reached $1.13M .

Earnings released on 31 Mar 2023

EPS came in at -$0.04 , while revenue for the quarter reached $1.13M .

Earnings released on 31 Dec 2022

Revenue for the quarter reached $1.08M .

Stock split effective on 5 Aug 2021

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

STEK Stock Performance

Access detailed STEK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run